Biocon updates on its shareholding in Syngene

Biocon and its subsidiary, Biocon Research jointly hold 85.54% stake in Syngene

Biocon announced that Silver Leaf Oak (Mauritius) has assigned its rights and obligations for acquisition of 10% stake in Syngene International (Syngene) to IVF Trustee Company (IVF), a fund advised by India Value Fund Advisors. Biocon Research, a wholly owned subsidiary of the Company has concluded such sale to IVF. Post conclusion of the above, Biocon and BRL jointly hold 85.54% stake in Syngene.

Powered by Capital Market - Live News